Literature DB >> 1963806

Relative potencies for barbiturate binding to the Torpedo acetylcholine receptor.

B A Dodson1, R R Urh, K W Miller.   

Abstract

1. The structural requirements of an allosteric barbiturate binding site on acetylcholine receptor-rich membranes isolated from Torpedo electroplaques have been characterized by the ability of fourteen barbiturates to displace [14C]-amobarbitone binding. 2. The barbiturates could be grouped into two classes with ten barbiturates producing a strong inhibition of [14C]-amobarbitone binding (class one) and with four exerting minimal effects (class two). 3. Eight of the ten class one barbiturates displaced essentially all of the [14C]-amobarbitone from its binding site, while, at their respective aqueous solubility limits, two of these barbiturates (thiopentone and dimethylbutylbarbitone (DMBB) inhibited [14C]-amobarbitone binding by nearly 80%. The apparent inhibition constants (KI) for the class one barbiturates ranged from 13 microM for amobarbitone to 2.8 mM for barbitone with the other eight agents lying in the range 100-600 microM, and having the rank order pentobarbitone approximately secobarbitone greater than thiopentone greater than DMBB greater than butabarbitone approximately phenobarbitone greater than aprobarbitone greater than allylbarbitone. 4. By contrast, the class two barbiturates had minimal effects even at close to saturating concentrations. [14C]-amobarbitone binding was reduced slightly (less than 30%) by hexobarbitone, mephobarbitone and methohexitone and was enhanced slightly (less than 20%) by metharbitone. 5. All of the class two, but none of the class one barbiturates, were N-methylated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1963806      PMCID: PMC1917748          DOI: 10.1111/j.1476-5381.1990.tb14145.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Erythrocyte ghost--buffer partition coefficients of phenobarbital, pentobarbital, and thiopental support the pH-partition hypothesis.

Authors:  K Korten; K W Miller
Journal:  Can J Physiol Pharmacol       Date:  1979-03       Impact factor: 2.273

2.  Barbiturates: their in vivo effects and potential biochemical mechanisms.

Authors:  J A Richter; J R Holtman
Journal:  Prog Neurobiol       Date:  1982       Impact factor: 11.685

Review 3.  Mechanism of action of barbiturates.

Authors:  I K Ho; R A Harris
Journal:  Annu Rev Pharmacol Toxicol       Date:  1981       Impact factor: 13.820

Review 4.  Drug interactions at the GABA receptor-ionophore complex.

Authors:  R W Olsen
Journal:  Annu Rev Pharmacol Toxicol       Date:  1982       Impact factor: 13.820

5.  Interactions of barbiturates of various pharmacological categories with benzodiazepine receptors.

Authors:  F Leeb-Lundberg; R W Olsen
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

6.  Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments from torpedo marmorata.

Authors:  T Heidmann; R E Oswald; J P Changeux
Journal:  Biochemistry       Date:  1983-06-21       Impact factor: 3.162

7.  Drug blockade of open end-plate channels.

Authors:  P R Adams
Journal:  J Physiol       Date:  1976-09       Impact factor: 5.182

8.  Kinetics of binding of [3H]acetylcholine to Torpedo postsynaptic membranes: association and dissociation rate constants by rapid mixing and ultrafiltration.

Authors:  N D Boyd; J B Cohen
Journal:  Biochemistry       Date:  1980-11-11       Impact factor: 3.162

9.  A comparison of the potencies of a series of barbiturates at the neuromuscular junction and on the central nervous system.

Authors:  S Lee-Son; B E Waud; D R Waud
Journal:  J Pharmacol Exp Ther       Date:  1975-11       Impact factor: 4.030

10.  Interaction of barbiturates with benzodiazepine receptors in the central nervous system.

Authors:  P Skolnick; K C Rice; J L Barker; S M Paul
Journal:  Brain Res       Date:  1982-02-04       Impact factor: 3.252

View more
  5 in total

1.  Identifying barbiturate binding sites in a nicotinic acetylcholine receptor with [3H]allyl m-trifluoromethyldiazirine mephobarbital, a photoreactive barbiturate.

Authors:  Ayman K Hamouda; Deirdre S Stewart; David C Chiara; Pavel Y Savechenkov; Karol S Bruzik; Jonathan B Cohen
Journal:  Mol Pharmacol       Date:  2014-02-21       Impact factor: 4.436

2.  Mechanisms of barbiturate inhibition of acetylcholine receptor channels.

Authors:  J P Dilger; R Boguslavsky; M Barann; T Katz; A M Vidal
Journal:  J Gen Physiol       Date:  1997-03       Impact factor: 4.086

Review 3.  Cholinergic mechanisms in physical dependence on barbiturates, ethanol and benzodiazepines.

Authors:  A Nordberg; G Wahlström
Journal:  J Neural Transm Gen Sect       Date:  1992

4.  Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor.

Authors:  David C Chiara; Selwyn S Jayakar; Xiaojuan Zhou; Xi Zhang; Pavel Y Savechenkov; Karol S Bruzik; Keith W Miller; Jonathan B Cohen
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

5.  Inhibition of the nicotinic acetylcholine receptor by barbiturates and by procaine: do they act at different sites?

Authors:  C S Yost; B A Dodson
Journal:  Cell Mol Neurobiol       Date:  1993-04       Impact factor: 5.046

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.